Bob Malone's Protege At DARPA DOMANE Is Your Vaccine Future

Dan Wattendorf's mRNA, originally known as DARPA ADEPT, already has a three year track record of tragedy.

Our Potomac Group called out bid rigging for DARPA ADEPT in March 2020, little did we know the inventor was Bob Malone's protege, Dan Wattendorf at DARPA.

Robert Malone sings the praises of the “Air Force Colonel put in charge of Operation Warp Speed” in a 2020 video, a hat tip to DARPA’s Dan Wattendorf.

Robert Malone Curriculum Vitae File In Florida Middle District Court On November 10th, 2021

https://ia802509.us.archive.org/27/items/gov.uscourts.flmd.395057/gov.uscourts.flmd.395057.30.6.pdf

Wattendorf was always the “DARPA guy” presenting with Moderna and BioNTECH as they rolled mRNA (DARPA ADEPT) out for various trials.

Elie Dolgen wrote over 25,000 words about “The Tangled History Of mRNA Vaccines” for Nature Magazine, but she didn’t mention DARPA once. Once you know DARPA has completely controlled the lifecycle of the mRNA vaccines, everything untangles.

What Elie Dolgen missed in her version of the mRNA history was that whenever DARPA wanted a technology, they sent in Bob Malone to start a fight over intellectual property rights. Everything is easy to understand after that.

https://archive.ph/e7pnH#selection-887.24-1975.41

Dolgen does mention DARPA once in her timeline chart of mRNA history, but if you are looking for the real story of DoD involvement in the history of military countermeasures, you need to follow the patent fights of Robert Malone. The Malone intellectual property rights fights are always with mentors who are two to three decades older than Malone and scientists who are recognized for their outstanding contributions by their peers. That’s another story for another time.

Meanwhile, the real story of DARPA funding Moderna and BioNTech (and thus Pfizer) tracks back to a whiteboard in Arlington, Virginia in 2010.

Wattendorf is clearly the man at DARPA that makes the DARPA ADEPT pitch which becomes the mRNA platform for both Moderna and BioNTech.

I have talked about the idea of releasing a nanoparticle that raises a unique antibody in the enemy terrorists on the field of battle and later being able to test suspected terrorists for those raised antibodies with the DARPA ECHO and DARPA DIGET technology.

DARPA ECHO can trace if a soldier or terrorist has been exposed to anthrax, thus “marking” the suspect as a terrorist or signaling an anthrax attack by the enemy by testing soldiers.

DARPA topics like ECHO and DIGET have long been discussed as battlefield “track and trace” tools used by the military in Iraq and Afghanistan being moved to domestic operations in the US by the FBI and DHS.

DARPA is not a technology-centered government Agency, but rather are mission-centered Agency providing a technological advantage for the warfighter in theory. More often, however, they have provided a “private DARPA” for investors who capitalize on the commercial uses of the warfighter-developed technology. DARPA ADEPT is the most recent example, and Bob Malone’s protege, Dan Wattendorf, is the key driver of this technology.

I do wish to give the journalist Elie Dolgen credit for putting Oligogen (later Gilead) on the mRNA timeline. She highlighted how Oligogen was creating chains of nucleotides

You can see the Robert Malone lab book claiming the mRNA patent in 1989, before he was a Ph.D. or an MD, in a lab with Nobel Prize winners. Robert Malone later claimed PTSD from the lab environment created by Inder Verma and was accused of intellectual property theft by Verma. Malone also had patent disputes with Phil Felgner, another giant in the field.

Oligogen, which later became Gilead, was started by the concept that a virus could change the genome of a bacteria.

https://pubmed.ncbi.nlm.nih.gov/6091052/

This simple step accomplished by Melton and Craig launched computational biology or what I call “trial and error” biology. You could load a virus with a nucleoside code, and then it would write itself into the DNA of a bacteria, otherwise known as a bacteriophage. You could alter the code of life for the first time.

With the financial support of the first Chairman of Gilead, the trial and error experimentation could begin in earnest. Oligogen’s ability to “generate oligos”, short chains of nucleosides in bacteriophages, created the capability to change life by changing the genome of a protein used in the body, and thus secure a patent for the “new and novel invention” of an altered gene for business exploitation.

Early funding and continued funding for the first 14 years of profitable operations were assured by making the ex-Secretary of Defense, Donald Rumsfeld, the Chairman of the Board. The other momentous event occurring at the same time was the race to find a therapeutic and a vaccine for HIV, a search that still continues to this day. Gilead was built on this idea of building short chains of nucleic acids, and then testing to see what happened when they injected into something. (A similar “shotgun experiment” would occur for the Human Genome Project and the mass vaccinations of DARPA ADEPT mRNA technology in 2020 to 2023.

DARPA and investors’ interest in the bacteriophage technology was that faster you could cycle the tests with robots and computers, the faster you could make guesses on what mutations to the genome might be beneficial. By learning from previous guess, you hopefully could “zero in” on the solution.

https://www.fiercepharma.com/marketing/gilead-zeros-community-groups-around-world-help-end-aids-epidemic

Author George Webb has written over fifty books Including “World War DARPA” and “No Dare Call It DARPA”.

Author George Webb has written over fifty books including several lengthy books on just the topic of DARPA.